Pliant Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DEEP TRACK CAPITAL, LP | 02/14/2025 | 5.97 M | $78.65 M | 0.00% | 9.83% |
BLACKROCK, INC. | 02/07/2025 | 5.18 M | $68.22 M | -0.75% | 8.53% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 4.63 M | $61.04 M | -4.14% | 7.63% |
FMR LLC | 02/13/2025 | 3.88 M | $51.05 M | -0.59% | 6.38% |
VANGUARD GROUP INC | 02/11/2025 | 3.23 M | $42.52 M | -8.44% | 5.32% |
PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 3.20 M | $42.11 M | 2.98% | 5.26% |
REDMILE GROUP, LLC | 02/14/2025 | 2.90 M | $38.13 M | -9.45% | 4.77% |
BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 2.77 M | $36.47 M | -7.82% | 4.56% |
DEUTSCHE BANK AG\ | 02/14/2025 | 2.55 M | $33.61 M | 66.31% | 4.20% |
TRV GP IV, LLC | 02/13/2025 | 2.13 M | $28.09 M | 0.00% | 3.51% |
POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 2.02 M | $26.54 M | 0.00% | 3.32% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 1.68 M | $22.14 M | -34.73% | 2.77% |
STATE STREET CORP | 02/14/2025 | 1.39 M | $18.24 M | -1.25% | 2.28% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.32 M | $17.34 M | -0.13% | 2.17% |
SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.32 M | $17.33 M | 100.00% | 2.17% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.28 M | $16.87 M | 0.00% | 2.11% |
PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.27 M | $16.67 M | -1.07% | 2.08% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.12 M | $14.76 M | 100.00% | 1.85% |
GREAT POINT PARTNERS LLC | 02/14/2025 | 1.06 M | $13.89 M | -44.77% | 1.74% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.05 M | $13.77 M | 0.55% | 1.72% |
CANDRIAM S.C.A. | 02/07/2025 | 900.10 K | $11.85 M | 8.03% | 1.48% |
MORGAN STANLEY | 02/14/2025 | 782.00 K | $10.30 M | -4.30% | 1.29% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 750.00 K | $9.88 M | 100.00% | 1.24% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 649.66 K | $8.56 M | 100.00% | 1.07% |
UBS GROUP AG | 02/14/2025 | 628.28 K | $8.27 M | 172.80% | 1.03% |
NORTHERN TRUST CORP | 02/14/2025 | 555.60 K | $7.32 M | 10.67% | 0.91% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 547.30 K | $7.21 M | 19.98% | 0.90% |
CHECKPOINT CAPITAL L.P. | 02/14/2025 | 535.49 K | $7.05 M | 40.92% | 0.88% |
BESSEMER GROUP INC | 02/13/2025 | 532.17 K | $7.01 M | 0.00% | 0.88% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 527.15 K | $6.94 M | -28.60% | 0.87% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 459.38 K | $6.05 M | 0.60% | 0.76% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 446.70 K | $5.88 M | 28.58% | 0.74% |
FERNWOOD INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 425.42 K | $5.60 M | -17.09% | 0.70% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 404.80 K | $5.33 M | 5.14% | 0.67% |
CITADEL ADVISORS LLC | 02/14/2025 | 401.69 K | $5.29 M | 1,045.91% | 0.66% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 394.50 K | $5.20 M | 1,215.00% | 0.65% |
AXA S.A. | 02/14/2025 | 346.94 K | $4.57 M | -0.16% | 0.57% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 300.00 K | $3.95 M | 0.00% | 0.49% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 297.36 K | $3.92 M | 0.00% | 0.49% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 281.19 K | $3.70 M | 0.00% | 0.46% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 206.95 K | $2.73 M | -38.31% | 0.34% |
JPMORGAN CHASE & CO | 02/12/2025 | 197.25 K | $2.60 M | 300.82% | 0.32% |
JANE STREET GROUP, LLC | 02/14/2025 | 193.70 K | $2.55 M | 5.21% | 0.32% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 184.38 K | $2.43 M | -0.09% | 0.30% |
JANE STREET GROUP, LLC | 02/14/2025 | 182.02 K | $2.40 M | -2.52% | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 160.52 K | $2.11 M | 2.10% | 0.26% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 142.40 K | $1.88 M | 100.00% | 0.23% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 139.57 K | $1.84 M | 18.35% | 0.23% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 135.70 K | $1.79 M | -14.01% | 0.22% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 134.80 K | $1.78 M | -45.23% | 0.22% |
Pliant Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 165 institutional investors and hedge funds held shares of Pliant Therapeutics, Inc.. The most heavily invested institutionals were:
Cornerstone Planning Group LLC: 0
GAMMA Investing LLC: 0
HARBOR CAPITAL ADVISORS, INC.: 0
Versant Capital Management, Inc: 0
SIGNATUREFD, LLC: 0
SALEM INVESTMENT COUNSELORS INC: 0
106.62% of Pliant Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 67.44 M shares in the last 24 months. This purchase volume represents approximately $113.97 M in transactions.